secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2024-05-13T23:59:59+00:00
Accession:  0001213900-24-042369
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix receives Nasdaq deficiency notice for insufficient stockholders' equity; faces potential delisting
--------------------------------------------------------------------------------

- Stockholders' equity was $1,404,476 for FY2023, below Nasdaq's $2.5M minimum requirement.
- Company must submit a compliance plan to Nasdaq by June 24, 2024.
- If plan accepted, Nasdaq may grant extension until November 4, 2024 to regain compliance.
- Failure to regain compliance could result in delisting of ONCO common stock.
- No immediate effect on listing; company can appeal any rejection decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024042369/0001213900-24-042369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390024042369/ea0205933-8k_oncone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-042369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer